| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Exact Sciences Corp (EXAS) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. EXAS is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 191.9K | - | - | |
| VP | 153.7K | - | - | |
| CFO | 138.7K | - | - | |
| VP | 137.2K | - | - | |
| Dir | 13.9K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 29, 2020 | Elliott Jeffrey Thomas79 | Chief Financial Officer | Sale+OE | 8,746 | $95.58 | $835,942.68 | -11.2% | |
| Jul 28, 2020 | Zanotti Katherine S50 | Director | Sell | 1,164 | $96.13 | $111,895.32 | -2.7% | |
| Apr 3, 2020 | Stenhouse Mark | President, Cologuard | Sale+OE | 11,948 | $56.69 | $677,332.12 | -28.8% | |
| Feb 28, 2020 | Doyle James Edward75 | Director | Sell | 2,000 | $77.54 | $155,080.00 | -5.8% | |
| Feb 28, 2020 | Elliott Jeffrey Thomas79 | Chief Financial Officer | Sale+OE | 2,383 | $80.17 | $191,045.11 | -3.9% | |
| Feb 28, 2020 | Conroy Kevin T81 | President And CEO | Sale+OE | 9,750 | $80.17 | $781,657.50 | -1.0% | |
| Feb 27, 2020 | Stenhouse Mark | President, Cologuard | Sale+OE | 1,051 | $80.27 | $84,363.77 | -6.0% | |
| Feb 27, 2020 | Elliott Jeffrey Thomas79 | Chief Financial Officer | Sale+OE | 1,627 | $80.27 | $130,599.29 | -2.8% | |
| Feb 27, 2020 | Conroy Kevin T81 | President And CEO | Sale+OE | 13,875 | $80.27 | $1,113,746.25 | -1.4% | |
| Feb 25, 2020 | Elliott Jeffrey Thomas79 | Chief Financial Officer | Sale+OE | 4,910 | $85.11 | $417,890.10 | -8.3% |